|
|
|
Financials-Sterling Biotech Limited| Sector: Chemicals - Others | | BSE:12299 | NSE:STERLINBIO | Bloomberg:SLT@IN | Reuters:STBI.BO | | Market Lot: 1 | Face Value: 1 | ISIN Demat: INE324C01038 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Mar-2019(12) |
31-Mar-2019(12) |
| Sales of Products/Services |
3495.34 |
3495.34 |
| Other Operating Income |
0.00 |
0.00 |
| Other Income |
23.30 |
23.30 |
| Total Income |
3518.64 |
3518.64 |
| Total Expenses |
-8101.07 |
-8101.07 |
| OPBDIT |
11619.71 |
11619.71 |
| Interest |
0.00 |
0.00 |
| Depreciation |
-2458.55 |
-2458.55 |
| Exceptional & Extraordinary Items |
-30098.99 |
-30098.99 |
| Prior Period Adjustments |
0.00 |
0.00 |
| Provision for Tax |
1378.86 |
1378.86 |
| After Tax Profit |
-33302.57 |
-33302.57 |
| Equity Capital |
0.00 |
0.00 |
| Reserves |
0.00 |
0.00 |
| Notes to Accounts |
|
|
|
| As on( Months ) |
31-Dec-05(12) |
|
31-Dec-04(12) |
|
31-Dec-03(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
4818.27 |
99.34 |
3899.09 |
98.45 |
2893.55 |
99.83 |
| Operating Income (OI) |
4850.07 |
100.00 |
3960.54 |
100.00 |
2898.61 |
100.00 |
| OPBDIT |
2278.82 |
46.99 |
1928.21 |
48.69 |
1444.75 |
49.84 |
| OPBDT |
1914.99 |
39.48 |
1488.23 |
37.58 |
949.06 |
32.74 |
| OPBT |
1491.75 |
30.76 |
1150.19 |
29.04 |
689.17 |
23.78 |
| Non-Operating Income |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Extraordinary/Prior Period |
-256.78 |
-5.29 |
-273.51 |
-6.91 |
-90.42 |
-3.12 |
| Tax |
117.70 |
2.43 |
85.00 |
2.15 |
146.00 |
5.04 |
| Profit after tax(PAT) |
1117.27 |
23.04 |
791.68 |
19.99 |
452.76 |
15.62 |
| Cash Profit |
1540.51 |
31.76 |
1129.72 |
28.52 |
712.65 |
24.59 |
| Dividend-Equity |
110.62 |
2.28 |
51.38 |
1.30 |
42.82 |
1.48 |
|
| As on |
31-Dec-05 |
|
31-Dec-04 |
|
31-Dec-03 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
8975.44 |
32.53 |
5965.56 |
47.91 |
4467.00 |
55.03 |
| Net Block |
7459.01 |
27.04 |
4867.31 |
39.09 |
3701.72 |
45.60 |
| Capital WIP |
5739.82 |
20.81 |
1710.63 |
13.74 |
750.34 |
9.24 |
| Investments |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
| Inventory |
2458.23 |
8.91 |
2162.18 |
17.36 |
1899.86 |
23.41 |
| Receivables |
1296.33 |
4.70 |
1128.57 |
9.06 |
890.75 |
10.97 |
| Other Current Assets |
10634.84 |
38.55 |
2583.14 |
20.75 |
874.28 |
10.77 |
| Balance Sheet Total(BT) |
27588.24 |
100.00 |
12451.83 |
100.00 |
8116.95 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
221.25 |
0.80 |
171.27 |
1.38 |
171.27 |
2.11 |
| Reserves |
8333.99 |
30.21 |
3667.32 |
29.45 |
3038.42 |
37.43 |
| Total Debt |
17213.38 |
62.39 |
7138.90 |
57.33 |
3786.88 |
46.65 |
| Creditors and Acceptances |
289.78 |
1.05 |
281.06 |
2.26 |
247.09 |
3.04 |
| Other current liab/prov. |
1529.83 |
5.55 |
1193.28 |
9.58 |
873.29 |
10.76 |
| Balance Sheet Total(BT) |
27588.24 |
100.00 |
12451.83 |
100.00 |
8116.95 |
100.00 |
|
| As on |
31-Dec-05 |
31-Dec-04 |
31-Dec-03 |
| OPBIT/Prod.cap.empl.(%) |
9.32 |
17.16 |
18.97 |
| PBIT/Cap. Employed (%) |
7.98 |
14.21 |
17.52 |
| PAT/Networth (%) |
13.06 |
20.62 |
14.11 |
| Tax/PBT (%) |
9.53 |
9.70 |
24.38 |
| Total Debt/Networth (x) |
2.01 |
1.86 |
1.18 |
| Long Term Debt/Networth (x) |
1.15 |
1.37 |
0.65 |
| PBDIT/Finance Charges (x) |
5.56 |
3.76 |
2.73 |
| Current Ratio (x) |
7.91 |
3.98 |
3.27 |
| RM Inventory (days consumption) |
409.01 |
449.58 |
545.61 |
| FG inventory (days cost of sales) |
97.26 |
105.47 |
121.20 |
| Receivables (days gross sales) |
98.20 |
105.65 |
112.36 |
| Creditors (days cost of sales) |
41.14 |
50.48 |
62.03 |
| Op. curr. assets (days OI) |
1074.00 |
541.00 |
461.00 |
|
|
Financials